BIOSAPIEN
-
Venture
VentureBioSapien Extends Pre-Series A Funding to Over $8M for Groundbreaking MediChip™ Cancer Treatment
BioSapien’s pre-Series A funding has surpassed $8 million, providing substantial capital to accelerate the development of its MediChip™ platform and…
Read More » -
FinTech
FinTechBiosapien Expands Its Pre-Series A Round to $7 Million to Advance the MediChip Platform
Biosapien has announced the expansion of its Pre-Series A funding round to $7 million to support the development of its…
Read More » -
FinTech
FinTech
BIOSAPIEN RAISES $5.5 MILLION IN PRE-SERIES A FUNDING
Abu Dhabi, UAE – 12 December 2024 –BioSapien – the patented drug delivery platform treating cancer ‘locally’ – announces its…
Read More »
